Clinical Trial Update: Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II) [Phase 3]

View source ↗

Summary

Phase 3 ODYSSEY COMBO II study comparing alirocumab vs ezetimibe on top of statin in high cardiovascular risk patients with hypercholesterolemia completed; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2015-11-06